Neurochemistry and biomarkers of narcolepsy and other primary and secondary hypersomnias

Sleep Medicine Clinics

Volumn 7, Issue 2, 2012, Pages 233-248

  Nishino, Seiji ^a   Deguzman, Carl ^a   Yamadera, Wataru ^a   Chiba, Shintaro ^a   Kanbayashi, Takashi ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarkers; CSF; EDS; Histamine; Hypocretin orexin; Idiopathic hypersomnia; Narcolepsy

Indexed keywords

4 AMINOBUTYRIC ACID; AQUAPORIN 4; DOPAMINE; DYNORPHIN; HISTAMINE; NEURONAL ACTIVITY REGULATED PENTRAXIN; NORADRENALIN; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; PENTRAXIN; SEROTONIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

CATAPLEXY; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; COERULEUS NEURON; DISEASE ASSOCIATION; DOG DISEASE; DOPAMINE RELEASE; GENE MUTATION; HUMAN; HYPERSOMNIA; HYPOCRETIN DEFICIENCY; LATERODORSAL TEGMENTAL NUCLEUS; NARCOLEPSY; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; RAPHE NEURON; REGULATORY MECHANISM; REM SLEEP; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; SOMNOLENCE; TEGMENTUM; THALAMOCORTICAL TRACT; TUBEROMAMMILLARY NEURON; VENTRAL TEGMENTUM;

EID: 84861613591     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2012.03.015     Document Type: Review

References (58)

1. ICSD-2 ICSD-2-International classification of sleep disorders, diagnostic and coding manual 2nd edition 2005 American Academy of Sleep Medicine Westchester (IL)
2. A. Verma, V. Anand, and N.P. Verma Sleep disorders in chronic traumatic brain injury J Clin Sleep Med 3 4 2007 357 362
3. S. Nishino, and T. Kanbayashi Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system Sleep Med Rev 9 4 2005 269 310
4. J.N. Marcus, C.J. Aschkenasi, and C.E. Lee Differential expression of orexin receptors 1 and 2 in the rat brain J Comp Neurol 435 1 2001 6 25
5. S. Nishino, E. Sakurai, and S. Nevsimalova Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls Sleep 32 2 2009 175 180
6. T. Kanbayashi, T. Kodama, and H. Kondo CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome Sleep 32 2 2009 181 187
7. S. Nishino, and E. Mignot Pharmacological aspects of human and canine narcolepsy Prog Neurobiol 52 1 1997 27 78
8. S. Nishino, S. Taheri, and J. Black The neurobiology of sleep in relation to mental illness D.S. Charney, E.J. Nestler, Neurobiology of mental illness 2004 Oxford University Press New York 1160 1179
9. C.B. Saper, T.E. Scammell, and J. Lu Hypothalamic regulation of sleep and circadian rhythms Nature 437 7063 2005 1257 1263
10. M.S. Aldrich, R.D. Chervin, and B.A. Malow Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy Sleep 20 8 1997 620 629
11. T. Sakurai, A. Amemiya, and M. Ishii Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior Cell 92 1998 573 585
12. L. De Lecea, T.S. Kilduff, and C. Peyron The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity Proc Natl Acad Sci U S A 95 1998 322 327
13. C. Peyron, D.K. Tighe, and A.N. van den Pol Neurons containing hypocretin (orexin) project to multiple neuronal systems J Neurosci 18 23 1998 9996 10015
14. L. Lin, J. Faraco, and R. Li The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene Cell 98 3 1999 365 376
15. R.M. Chemelli, J.T. Willie, and C.M. Sinton Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 98 1999 437 451
16. S. Nishino, B. Ripley, and S. Overeem Hypocretin (orexin) deficiency in human narcolepsy Lancet 355 9197 2000 39 40
17. C. Peyron, J. Faraco, and W. Rogers A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 6 9 2000 991 997
18. E. Mignot, G.J. Lammers, and B. Ripley The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias Arch Neurol 59 10 2002 1553 1562
19. A. Crocker, R.A. Espana, and M. Papadopoulou Concomitant loss of dynorphin, NARP, and orexin in narcolepsy Neurology 65 8 2005 1184 1188
20. M. Honda, K.S. Eriksson, and S. Zhang IGFBP3 colocalizes with and regulates hypocretin (orexin) PLoS One 4 1 2009 e4254
21. Y. Yoshida, M. Okun, and E. Mignot CSF dynorphine A(1-8) levels are not altered in hypocretin-deficient human narcolepsy Sleep 25 Abstract Suppl 2002 A472 2002
22. B. Ripley, N. Fujiki, and M. Okura Hypocretin levels in sporadic and familial cases of canine narcolepsy Neurobiol Dis 8 3 2001 525 534
23. T.C. Thannickal, R. Nienhuis, and J.M. Siegel Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy Sleep 32 8 2009 993 998
24. B. Roth Narkolepsie und hypersomnie 1962 VEB Verlag Volk und Gesundheit Berlin
25. C. Bassetti, and M.S. Aldrich Idiopathic hypersomnia. A series of 42 patients Brain 120 Pt 8 1997 1423 1435
26. C. Bassetti, M. Gugger, and M. Bischof The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A) Sleep Med 4 1 2003 7 12
27. T. Sakurai Roles of orexins in regulation of feeding and wakefulness Neuroreport 13 8 2002 987 995
28. J.T. Willie, R.M. Chemelli, and C.M. Sinton To eat or to sleep? Orexin in the regulation of feeding and wakefulness Annu Rev Neurosci 24 2001 429 458
29. N. Fujiki, Y. Yoshida, and B. Ripley Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation Neuroreport 12 5 2001 993 997
30. M.G. Lee, O.K. Hassani, and B.E. Jones Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle J Neurosci 25 28 2005 6716 6720
31. G. Aston-Jones, S. Chen, and Y. Zhu A neural circuit for circadian regulation of arousal Nat Neurosci 4 7 2001 732 738
32. Y. Yoshida, N. Fujiki, and T. Nakajima Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities Eur J Neurosci 14 7 2001 1075 1081
33. C.B. Saper, T.C. Chou, and T.E. Scammell The sleep switch: hypothalamic control of sleep and wakefulness Trends Neurosci 24 12 2001 726 731
34. S. Nishino, T. Kanbayashi, and N. Fujiki CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies Neurology 61 6 2003 823 825
35. S. Overeem, J. Dalmau, and L. Bataller Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis Neurology 62 1 2004 138 140
36. T. Kanbayashi, T. Shimohata, and I. Nakashima Symptomatic narcolepsy in MS and NMO patients; new neurochemical and immunological implications Arch Neurol 66 2009 1563 1566
37. G. Poirier, J. Montplaisir, and M. Dumont Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis Neurology 37 4 1987 693 695
38. B. Ripley, S. Overeem, and N. Fujiki CSF hypocretin/orexin levels in narcolepsy and other neurological conditions Neurology 57 12 2001 2253 2258
39. M. Amiry-Moghaddam, and O.P. Ottersen The molecular basis of water transport in the brain Nat Rev Neurosci 4 12 2003 991 1001
40. S.J. Pittock, B.G. Weinshenker, and C.F. Lucchinetti Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression Arch Neurol 63 7 2006 964 968
41. V.A. Lennon, T.J. Kryzer, and S.J. Pittock IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel J Exp Med 202 4 2005 473 477
42. J. Montplaisir, J. de Champlain, and S.N. Young Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF Neurology 32 11 1982 1299 1302
43. K.F. Faull, L.C. Zeller-DeAmicis, and L. Radde Biogenic amine concentrations in the brains of normal and narcoleptic canines: current status Sleep 9 1 1986 107 110
44. M.S. Aldrich, Z. Hollingsworth, and J.B. Penney Dopamine-receptor autoradiography of human narcoleptic brain Neurology 42 1992 410 415
45. C. Hublin, J. Launes, and P. Nikkinen Dopamine D2-receptors in human narcolepsy: a SPECT study with 123I-IBZM Acta Neurol Scand 90 3 1994 186 189
46. J. Rinne, C. Hublin, and M. Partinen PET study of human narcolepsy: no increase in striatal dopamine D2-receptors Neurology 45 1995 1735 1738
47. I.N. Mefford, T.L. Baker, and R. Boehme Narcolepsy: biogenic amine deficits in an animal model Science 220 1983 629 632
48. S. Nishino, N. Fujiki, and B. Ripley Decreased brain histamine contents in hypocretin/orexin receptor-2 mutated narcoleptic dogs Neurosci Lett 313 3 2001 125 128
49. S. Nishino, J. Riehl, and J. Hong Is narcolepsy REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans Neurosci Res 38 4 2000 437 446
50. K.S. Eriksson, O. Sergeeva, and R.E. Brown Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus J Neurosci 21 23 2001 9273 9279
51. A. Yamanaka, N. Tsujino, and H. Funahashi Orexins activate histaminergic neurons via the orexin 2 receptor Biochem Biophys Res Commun 290 4 2002 1237 1245
52. K.F. Faull, C. Guilleminault, and P.S. Berger Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia Ann Neurol 13 3 1983 258 263
53. J.S. Lin Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons Sleep Med Rev 4 5 2000 471 503
54. H. Haas, and P. Panula The role of histamine and the tuberomamillary nucleus in the nervous system Nat Rev Neurosci 4 2 2003 121 130
55. Z.L. Huang, W.M. Qu, and W.D. Li Arousal effect of orexin A depends on activation of the histaminergic system Proc Natl Acad Sci U S A 98 17 2001 9965 9970
56. T. Mochizuki, A. Yamatodani, and K. Okakura Circadian rhythm of histamine release from the hypothalamus of freely moving rats Physiol Behav 51 2 1992 391 394
57. R.E. Strecker, J. Nalwalk, and L.J. Dauphin Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: an in vivo microdialysis study Neuroscience 113 3 2002 663 670
58. S. Soya, Y.H. Song, and T. Kodama CSF histamine levels in rats reflect the central histamine neurotransmission Neurosci Lett 430 2008 224 229